Literature DB >> 3300230

Sotalol: a beta blocker with unique antiarrhythmic properties.

B N Singh, K Nademanee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3300230     DOI： 10.1016/0002-8703(87)90316-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  12 in total

Review 1.  Comparative hemodynamics of antiarrhythmic drugs.

Authors:  M Sami
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

2.  Comparison of electrophysiological and antiarrhythmic effects of vernakalant, ranolazine, and sotalol in canine pulmonary vein sleeve preparations.

Authors:  Serge Sicouri; Marc Pourrier; John K Gibson; Joseph J Lynch; Charles Antzelevitch
Journal:  Heart Rhythm       Date:  2011-10-20       Impact factor: 6.343

Review 3.  Drug effects on the electrocardiogram. A review of their clinical importance.

Authors:  J D Symanski; L S Gettes
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

Review 4.  2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures.

Authors:  Gyorgy Frendl; Alissa C Sodickson; Mina K Chung; Albert L Waldo; Bernard J Gersh; James E Tisdale; Hugh Calkins; Sary Aranki; Tsuyoshi Kaneko; Stephen Cassivi; Sidney C Smith; Dawood Darbar; Jon O Wee; Thomas K Waddell; David Amar; Dale Adler
Journal:  J Thorac Cardiovasc Surg       Date:  2014-06-30       Impact factor: 5.209

5.  [Torsade de pointes tachycardia during administration of quinidine and verapamil in atrial fibrillation].

Authors:  M Karch; C Schmitt; A Plewan; G Schmidt; A Schömig
Journal:  Herz       Date:  1997-02       Impact factor: 1.443

6.  Antiarrhythmic properties of tedisamil (KC8857), a putative transient outward K+ current blocker.

Authors:  G N Beatch; S Abraham; B A MacLeod; N R Yoshida; M J Walker
Journal:  Br J Pharmacol       Date:  1991-01       Impact factor: 8.739

7.  A mechanism of D-(+)-sotalol effects on heart rate not related to beta-adrenoceptor antagonism.

Authors:  C Funck-Brentano; D J Silberstein; D M Roden; A J Wood; R L Woosley
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

8.  Stereospecific high-performance liquid chromatographic assay of sotalol in plasma.

Authors:  R A Carr; R T Foster; N H Bhanji
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

9.  Long-term antiarrhythmic efficacy and safety of d-sotalol in patients with ventricular tachycardia and a low ejection fraction.

Authors:  K T Koch; D R Düren; P A van Zwieten
Journal:  Cardiovasc Drugs Ther       Date:  1995-06       Impact factor: 3.727

Review 10.  Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.

Authors:  A Fitton; E M Sorkin
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.